Business Daily from THE HINDU group of publications
Thursday, Sep 07, 2006


News
Features
Stocks
Cross Currency
Shipping
Archives
Google

Group Sites

Corporate - Venture Capital
Actis to invest $42 m in Paras Pharma

Our Bureau

New Delhi , Sept. 6

Private equity investor Actis is to invest $42 million in the Gujarat-based over-the-counter healthcare and personal care company, Paras Pharmaceuticals Ltd, an Actis release said.

According to industry sources, Actis has picked up around 25 per cent stake in the company through the deal.

Commenting on the deal, Mr J.M. Trivedi, Partner, Actis South Asia, said, "We believe that the founders of Paras, have built a strong business through a combination of excellent brand building and the development of a strong distribution network, from which they intend to drive rapid growth in the personal care segment going forward. Actis will actively work with the management of Paras to achieve this objective. This partnership will benefit all stakeholders."

Mr Girish Patel, CEO of Paras, said, "We have a strong relationship with the Actis team and are impressed by their ability to add value. We welcome Actis as an active partner and are sure that the association will help us take the business to the next level of growth. The capital infusion is to help us expand our business and strengthen our brand and product portfolio."

Paras has a portfolio of 15 successful brands, including the Moov and D'Cold brands.

More Stories on : Venture Capital | Pharmaceuticals

Article E-Mail :: Comment :: Syndication :: Printer Friendly Page



Stories in this Section
Natco Pharma fixes Rs 150 ceiling for buyback


ELCINA award for Videocon chief
HC directs Ministry to decide on Madras Fert chief
Meet on boardroom processes
ICI Paints to spend Rs 1,500 cr on buys
Bengal Govt okays Hind Motors' Uttarpara plant revival plan
VSP starts expansion work
Bengal to invite IOC as anchor investor
AP firms set up offices in UK
`There's a premium that foreign companies need to pay for their India footprint'
Actis to invest $42 m in Paras Pharma
Tata Coffee rights: Tata Tea firm on commitments
Suzuki may use Rlys freight services for car exports
Medopharm launches new antibiotic


The Hindu Group: Home | About Us | Copyright | Archives | Contacts | Subscription
Group Sites: The Hindu | Business Line | Sportstar | Frontline | The Hindu eBooks | The Hindu Images | Home |

Copyright © 2006, The Hindu Business Line. Republication or redissemination of the contents of this screen are expressly prohibited without the written consent of The Hindu Business Line